El-Khoueiry, Anthony B., Kim, Richard D., Harris, William P., Sung, Max W., Waldschmidt, Dirk, Iqbal, Syma, Zhang, Xiaojing (Amily), Nakajima, Keiko and Galle, Peter R. (2020). Phase Ib study of regorafenib (REG) plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC). J. Clin. Oncol., 38 (4). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
El-Khoueiry, Anthony B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kim, Richard D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Harris, William P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sung, Max W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Waldschmidt, DirkUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Iqbal, SymaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zhang, Xiaojing (Amily)UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Nakajima, KeikoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Galle, Peter R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-345869
Journal or Publication Title: J. Clin. Oncol.
Volume: 38
Number: 4
Date: 2020
Publisher: AMER SOC CLINICAL ONCOLOGY
Place of Publication: ALEXANDRIA
ISSN: 1527-7755
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/34586

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item